stars 1 stars 2 stars 3

YURiA-PHARM – dynamically growing company Pharmaceutical company YURiA-PHARM was found in 1998. Today YURiA-PHARM is the leader manufacturer of solutions for infusion not only in Ukraine but also in CIS. We supply medical facilities with more than 100 items of bloodand plasma substitute solutions, original infusion drugs, antibiotics, fungicidal drugs, syrups, antiseptics, parenteral feeding preparations, anti-tuberculosis drugs, syringes, I.V. sets. The assortment of products fully covers the requirements of stationary curative establishments in infusion therapy. Our product line sums up to more than 40 preparations. Annual turnover of the company exceeds 60 mln bottles per year. YURiA-PHARM confidently takes in the leading position in the export markets We deliver our products to Moldova, Kazakhstan, Uzbekistan, Azerbaijan, Tajikistan, Kirgizia, Turkmenistan and Georgia. More than 100 items are now being registered for usage in different countries and the number is continuously growing. In 2008 YURiA-PHARM Corporation has received a Certificate of compliance to international quality management standards ISO 9001 (9001:2009). In 2011 YURiA-PHARM Corporation has completed WHO-GMP certification. YURiA-PHARM – some short facts: - leader in production of I.V. solutions - annual growth rate more than 40% - more than 100 items in the product line - total headcount more than 800 employees - annual turnover more than 60 mln units - exports to 10 countries - 80% of annual net profit is invested in modernization of production - each year about 10 new medical preparations are delivered - system quality control ISO 9001 : 2009 operates - GMP-certified manufacturing

Website https://www.uf.ua/
Revenue $8.1 million
Employees 486 (316 on RocketReach)
Founded 1998
Address 10 M. Amosova St, Kiev, Kyiv City, UA
Phone +380 44 246 8383
Technologies
Industry Pharmaceutical Manufacturing, Manufacturing General, Medicine, Manufacturing, Pharmaceutics, Medical Products, Infusion, Pharmaceutical Company, Anti-Tb Therapy, Infusion Therapy, Pain Management, Лекарства, Здоровье, Фармацевтика, Инфузионная Терапия
Web Rank 762637
Keywords Pharmaceutical Products, Drug Manufacturer, Pharmaceutical Manufacturing, Iv Solutions, Medical Supplies, Medicine Supplier, Healthcare, Injectable Drugs, Hospital Supplies, Pharma Manufacturing, Prescription Drugs, Sterile Manufacturing, Healthcare Products, Drug Delivery, Medical Devices, Pharmaceutical Ingredients, Drug Development, Clinical Trials
Competitors Sanofi, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Sandoz, Valeant Pharmaceuticals, STADA APAC, Prueba GR, KK Krka, Macintyre Electronic Design Associates Inc +19 more (view full list)
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies

YURiA-PHARM LLC Questions

The YURiA-PHARM LLC annual revenue was $8.1 million in 2026.

Mykola Gumeniuk is the CEO of YURiA-PHARM LLC.

316 people are employed at YURiA-PHARM LLC.

YURiA-PHARM LLC is based in Kiev, Kyiv City.

The NAICS codes for YURiA-PHARM LLC are [325, 32, 3254, 32541].

The SIC codes for YURiA-PHARM LLC are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users